Catalio Capital Management, Lp Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Catalio Capital Management, Lp disclosed 38 stock positions valued at approximately $532.10M as of quarter-end June 30, 2026. The largest holdings include AVALYN PHARMACEUTICALS INC, JOHNSON & JOHNSON, and GILEAD SCIENCES INC.
- Report Period
- June 30, 2026
- No. of Stocks
- 38
- Portfolio Value
- $532.10M
Holdings by Sector
Catalio Capital Management, Lp Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| AVALYN PHARMACEUTICALS INC | AVLN | Other | 10.37% | 1,675,830 | +1,675,830 | +100.00% | $55,168,324 |
| JOHNSON & JOHNSON | JNJ | Healthcare | 6.63% | 138,946 | +18,106 | +14.98% | $35,288,116 |
| GILEAD SCIENCES INC | GILD | Healthcare | 6.39% | 269,309 | +105,404 | +64.31% | $34,024,499 |
| BRIDGEBIO PHARMA INC | BBIO | Healthcare | 6.37% | 455,041 | +23,027 | +5.33% | $33,891,454 |
| SYNDAX PHARMACEUTICALS INC | SNDX | Healthcare | 4.99% | 1,215,698 | +172,028 | +16.48% | $26,575,158 |
| DEFINIUM THERAPEUTICS INC | DFTX | Other | 4.97% | 562,672 | -475,312 | -45.79% | $26,468,091 |
| BRISTOL-MYERS SQUIBB CO | BMY | Healthcare | 4.47% | 412,961 | -7,766 | -1.85% | $23,794,813 |
| PARABILIS MEDICINES INC | PBLS | Other | 4.24% | 824,043 | +824,043 | +100.00% | $22,554,057 |
| NATERA INC | NTRA | Healthcare | 4.19% | 82,181 | +11,274 | +15.90% | $22,308,032 |
| INCYTE CORP | INCY | Healthcare | 4.08% | 191,627 | +9,526 | +5.23% | $21,722,837 |
| SEPTERNA INC | SEPN | Other | 3.37% | 536,152 | +241,792 | +82.14% | $17,955,730 |
| MINERALYS THERAPEUTICS INC | MLYS | Healthcare | 3.29% | 648,722 | +209,681 | +47.76% | $17,502,520 |
| HEARTFLOW INC | HTFL | Other | 3.21% | 583,055 | +179,467 | +44.47% | $17,106,834 |
| CORVUS PHARMACEUTICALS INC | CRVS | Healthcare | 3.03% | 1,080,888 | +188,955 | +21.18% | $16,148,467 |
| STRUCTURE THERAPEUTICS INC | GPCR | Healthcare | 2.79% | 276,550 | +21,171 | +8.29% | $14,842,438 |
| PROTAGONIST THERAPEUTICS INC | PTGX | Healthcare | 2.46% | 106,799 | +106,799 | +100.00% | $13,091,421 |
| DISC MEDICINE INC | IRON | Healthcare | 2.19% | 159,384 | +36,406 | +29.60% | $11,657,346 |
| EDWARDS LIFESCIENCES CORP | EW | Healthcare | 2.12% | 124,778 | -19,829 | -13.71% | $11,287,418 |
| AXSOME THERAPEUTICS INC. | AXSM | Healthcare | 1.99% | 43,182 | +43,182 | +100.00% | $10,569,658 |
| ULTRAGENYX PHARMACEUTICAL IN | RARE | Healthcare | 1.98% | 316,252 | -534,545 | -62.83% | $10,559,654 |
| KAILERA THERAPEUTICS INC | KLRA | Other | 1.94% | 468,750 | +468,750 | +100.00% | $10,326,563 |
| KARYOPHARM THERAPEUTICS INC | KPTI | Other | 1.73% | 940,855 | +43,146 | +4.81% | $9,192,153 |
| ODYSSEY THERAPEUTICS INC | ODTX | Other | 1.61% | 457,839 | +457,839 | +100.00% | $8,566,168 |
| KARDIGAN INC | KARD | Other | 1.40% | 312,500 | +312,500 | +100.00% | $7,453,125 |
| ELEDON PHARMACEUTICALS INC | ELDN | Healthcare | 1.26% | 1,695,071 | +55,255 | +3.37% | $6,678,580 |
| 4D MOLECULAR THERAPEUTICS IN | FDMT | Healthcare | 1.18% | 471,254 | +471,254 | +100.00% | $6,267,678 |
| VERADERMICS INC | MANE | Other | 1.06% | 45,856 | -127,726 | -73.58% | $5,637,537 |
| DYNE THERAPEUTICS INC | DYN | Healthcare | 1.02% | 244,929 | -38,025 | -13.44% | $5,439,873 |
| FRACTYL HEALTH INC | GUTS | Healthcare | 0.92% | 6,168,749 | +676,883 | +12.33% | $4,900,454 |
| IMMUNOCORE HLDGS PLC | IMCR | Healthcare | 0.88% | 148,045 | +63,693 | +75.51% | $4,700,429 |
Showing 30 of 38 holdings in the latest reporting period.